IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Total Equity Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Total Equity
kr115.8m
CAGR 3-Years
-31%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Equity
kr106.8m
CAGR 3-Years
-51%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Equity
kr2.9B
CAGR 3-Years
53%
CAGR 5-Years
44%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Equity
kr7.7B
CAGR 3-Years
52%
CAGR 5-Years
132%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Equity
kr610.7m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Equity
kr4.4B
CAGR 3-Years
108%
CAGR 5-Years
172%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Total Equity?
Total Equity
115.8m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Total Equity amounts to 115.8m SEK.

What is IRLAB Therapeutics AB's Total Equity growth rate?
Total Equity CAGR 5Y
-11%

Over the last year, the Total Equity growth was -60%. The average annual Total Equity growth rates for IRLAB Therapeutics AB have been -31% over the past three years , -11% over the past five years .

Back to Top